637
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Performance of Methods to Assess Kidney Function in a Predominantly Overweight Sample of Patients with Liver Disease

, , , , &
Pages 249-256 | Received 19 Sep 2012, Accepted 29 Oct 2012, Published online: 26 Nov 2012

REFERENCES

  • Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant. 2006;6(11):2651–2659.
  • Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology. 2002;35(5):1179–1185.
  • Mehrabi A, Fonouni H, Ayoub E, . A single center experience of combined liver kidney transplantation. Clin Transplant. 2009;23(Suppl. 21):102–114.
  • Tanriover B, Mejia A, Weinstein J, . Analysis of kidney function and biopsy results in liver failure patients with renal dysfunction: a new look to combined liver kidney allocation in the post-MELD era. Transplantation. 2008;86(11):1548–1553.
  • Henriksen JH, Brochner-Mortensen J, Malchow-Moller A, Schlichting P. Over-estimation of glomerular filtration rate by single injection [51Cr]EDTA plasma clearance determination in patients with ascites. Scand J Clin Lab Invest. 1980;40(3):279–284.
  • Skluzacek PA, Szewc RG, Nolan CR, 3rd, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis. 2003;42(6):1169–1176.
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461–470.
  • Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem. 1991;37(5):695–700.
  • Cocchetto DM, Tschanz C, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit. 1983;5(2):161–168.
  • Hull JH, Hak LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM. Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther. 1981; 29(4):516–521.
  • Orlando R, Floreani M, Padrini R, Palatini P. Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis. Clin Nephrol. 1999;51(6):341–347.
  • Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003;41(2):269–278.
  • MacAulay J, Thompson K, Kiberd BA, Barnes DC, Peltekian KM. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? Can J Gastroenterol. 2006;20(8):521–526.
  • Francoz C, Prie D, Abdelrazek W, . Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl. 2010;16(10): 1169–1177.
  • Rognant N, Bacchetta J, Dubourg L, . What is the best alternative to inulin clearance to estimate GFR in patients with decompensated alcoholic cirrhosis? Nephrol Dial Transplant. 2010;25(11):3569–3575.
  • Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol. 2000;54(3):203–209.
  • Gerbes AL, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut. 2002;50(1):106–110.
  • Orlando R, Mussap M, Plebani M, . Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem. 2002;48(6 Pt 1):850–858.
  • Poge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant. 2006;21(3):660–664.
  • Xirouchakis E, Marelli L, Cholongitas E, . Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol. 2011;6(1):84–92.
  • Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18(10):2024–2031.
  • Larsson A, Malm J, Grubb A, Hansson LO. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest. 2004;64(1):25–30.
  • Matzke GR, McGory RW, Halstenson CE, Keane WF. Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother. 1984;25(4):433–437.
  • Matzke GR, Zhanel GG, Guay DR. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet. 1986;11(4):257–282.
  • Kamath PS, Wiesner RH, Malinchoc M, . A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2):464–470.
  • Glofil-125. Package Insert. Kirkland, WA: QOL Medical; 2000.
  • Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999; 59(1):1–8.
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl. 1):S1–S266.
  • Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta. 2003;338(1–2):87–90.
  • Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001;47(11):2055–2059.
  • Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl. 2004;10(2):301–309.
  • Woitas RP, Stoffel-Wagner B, Flommersfeld S, . Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem. 2000;46(5):712–715.
  • Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM. Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant. 2005;20(10):2024–2028.
  • Demirovic JA, Pai AB, Pai MP. Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharm. 2009;66(7):642–648.
  • Hudson JQ, Mason DL, Huch KM. Estimates of kidney function in obese African Americans with chronic kidney disease. Nephron Clin Pract. 2010;118(2):c101–c108.
  • Rigalleau V, Chauveau P, Lasseur C, . Indexing glomerular filtration rate for body surface area is useful in obese subjects. Nephrol Dial Transplant. 2006;21(3):821.
  • Schuck O, Teplan V, Stollova M, Skibova J. Estimation of glomerular filtration rate in obese patients with chronic renal impairment based on serum cystatin C levels. Clin Nephrol. 2004;62(2):92–96.
  • Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis. 2005;46(2):233–241.
  • Levey AS, Stevens LA, Schmid CH, . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604–612.
  • Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol. 2010;52(4):605–613.
  • Lim YS, Larson TS, Benson JT, . Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010;52(4):523–528.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.